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ABSTRACT: Multiplex Automated Genome Engineering (MAGE)
allows simultaneous mutagenesis of multiple target sites in
bacterial genomes using short oligonucleotides. However, large-
scale mutagenesis requires hundreds to thousands of unique
oligos, which are costly to synthesize and impossible to scale-up
by traditional phosphoramidite column-based approaches. Here,
we describe a novel method to amplify oligos from microarray
chips for direct use in MAGE to perturb thousands of genomic
sites simultaneously. We demonstrated the feasibility of large-
scale mutagenesis by inserting T7 promoters upstream of 2585
operons in E. coli using this method, which we call Microarray-
Oligonucleotide (MO)-MAGE. The resulting mutant library was
characterized by high-throughput sequencing to show that all
attempted insertions were estimated to have occurred at an
average frequency of 0.02% per locus with 0.4 average insertions per cell. MO-MAGE enables cost-effective large-scale targeted
genome engineering that should be useful for a variety of applications in synthetic biology and metabolic engineering.
KEYWORDS: genome engineering, MAGE, metabolic engineering, microarray, library synthesis
A core aim of metabolic engineering and synthetic biologyis to redesign and create biological systems with useful
purposes, for example cell factories that produce novel
medicines1 and chemicals.2 To achieve these goals, the need of
a large set of efficient tools have spurred extensive research efforts
dedicated to expanding the synthetic biology toolbox.3,4 The
alteration of gene expression and rewiring of metabolic networks
are important for basic research and metabolic engineering, and
methods such as transposon sequencing (Tn-seq)5 and trackable
multiplex recombineering (TRMR)6 allow genomic perturba-
tions into a large number of sites. However, these approaches do
not allow combinations of several mutations in individual cells
and are confined mostly to generating gene knockouts that
require integration of a sizable selectable marker, for which there
are limited options. The recent development of Multiplex
Automated Genome Engineering (MAGE)7 enables rapid and
efficient targeted modification of the genome through iterative
cycles of λ-Red mediated recombination using multiple
oligonucleotides at once. MAGE with multiple degenerate oligos
can be applied toward genome mutagenesis through a semi-
rational approach, where specific targets are randomly altered to
limit mutagenesis to only selected targets. Such application of
MAGE has been shown to be useful for metabolic optimization
to increase the biosynthetic production of lycopene and indigo
in E. coli.8,9 In theory, MAGE should be amenable to targeted
mutagenesis using thousands of oligos all at once to target hundreds
to thousands of chromosomal targets. This capability will open new
possibilities for many large-scale genome engineering projects.10
Mutagenesis of thousands of genomic targets by MAGE re-
quires large oligo library pools. However, synthesis of thousands
of MAGE oligos by traditional column-based phosphoramidite
chemistry is impractical in both time and cost. Recent develop-
ments in high-fidelity oligonucleotide microarray technologies
have enabled the construction of large libraries (>55 000 oligos)
of 200 bp oligos11 at a significantly lower cost and turn-
around time compared to oligos produced by column-based
synthesis.12−14 Here, we describe Microarray Oligonucleotide
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(MO)-MAGE, a novel method to generate thousands of oligos
suitable for large-scale genome engineering by MAGE and
demonstrate its application for fast and robust targeted
mutagenesis of the E. coli genome.
■ RESULTS AND DISCUSSION
Using a computational framework for MAGE oligo design
(MODEST),15 we first identified perturbation targets of the
Escherichia coli genome that included most regulatory and
protein coding regions (See Table 1 for details about which genes
were targeted). Protein coding perturbations were made through
the generation of a nonsense and frameshift mutation within the
first 5% of the open-reading frame to functionally introduce a
reversible gene knockout. Regulatory perturbations included
up-regulation (“RBS up”) using consensus (AGGAGG), down-
regulation (“RBS down”) using anticonsensus (TCCTCC) ribo-
somal binding sites, or insertion of a T7 promoter sequence
(TAATACGACTCACTATAGGG) upstream of operons. A sum-
mary of the genomic perturbation design is given in Table 1. In all,
the designed oligo library constituted 13 000 possible targeted per-
turbations against theE. coli genome (see Supporting Information).
Traditional column-based synthesis of 90mer MAGE oligos
of this library size would take months to years to generate at a
cost of aproximately $500,000 USD. Thus, we turned to new
approaches in long oligonucleotide synthesis using DNA micro-
arrays.11 A 130mer single-stranded DNA library was generated
using the Oligo Library Synthesis (OLS) platform from Agilent
Technologies (Santa Clara, CA, U.S.A.). Because the amount of
oligos needed for MAGE is much higher than the total yield from
microarray synthesis (μM versus pM), we devised a PCR-based
amplification protocol to generate a renewable supply of MAGE-
compatible oligo pool from our initial microarray-derived oligo
library, which we describe in greater detail later.
Each oligo library subpool (e.g., CDS Knockout, T7 insertion,
RBS up, RBS down) was designed with a unique set of barcodes,
which allowed for selective amplification of only the subpool
library by using specific primers (see Figure 1). A total volume of
38.4 mL of PCR was first performed to ensure that we generated
enough oligos for >10 MAGE cycles. One of the two primers
used for the PCR contained a 5′-phosphothioester bond and a
3′-uracil, while the other contained a 5′ phosphorylated group.
The resulting amplicons contain a 5′-phosphothioester bond on
the MAGE-compatible sense-strand and a 5′-phosphate on the
reverse complement strand. This 130 bp double-stranded (ds)
DNA amplicon was digested with λ-exonuclease. Since
λ-exonuclease has much higher activity for unphosphorylated
substrates16 and its activity is blocked by phosphothioester
bonds, the digest results in a 130mer single-stranded (ss) DNA
library of the MAGE-compatible sense-strand that contained the
phosphothioester bond at the 5′ end. Subsequently, the 20 bp
flanking barcodes used for PCR amplification of the subpools
were removed from each end of the ssDNA to yield unique
90mer oligos needed for high efficiency MAGE. This was
accomplished by first digesting the 130mer ssDNA library, which
contained an internal uracil at the barcode junction from the
previous PCR (see Figure 1), with an uracil DNA glycosylase,
endonuclease VIII,17 which removes the uracil from the ssDNA
strand. The uracil excision effectively removes the 20mer barcode
at the 5′ end of the ssDNA library, yielding a 110mer library. The
3′ barcode was designed with a DpnII restriction site placed
immediately after the target oligo sequence. To remove the 3′
barcode, a guide primer complementary to the 3′ barcode
including the DpnII site was used to hybridize to the 110mer
oligo and was digested with DpnII to yield the designed 90mer
oligo library. The use of a guide primer ensured that the
remaining part of the single-stranded oligo is not digested by
DpnII, which only cuts dsDNA. The resulting oligo library
contained unique 90 base single-stranded oligos.
Gel electrophoresis of the oligos was performed after each step
to ensure that the processing resulted in the expected prod-
uct (see Figure 2a and b). Serial dilutions of the library were
further visualized on a TBE-UREA gel to estimate library concen-
tration using ImageJ.18 We estimate that a typical amplification
generates 1.4 nmols of oligos (∼12 μM in 115 μL), which is
sufficient for 14 MAGE cycles at 2 μM per 50 μL reaction per
cycle.
Table 1. Overview of Oligos Designed and Synthesized on the
Micro-Array Chipa
targets general TFs genes targeted
CDS knock outs 3798 3633 167 all nonessential, non-pseudo-,
non-ncRNA
T7 promoters 2723 2585 138 all non-pseudo-, non-ncRNA,b
RBS up 3323 3172 151 all non-pseudo-, non-ncRNA
RBS down 3099 2948 151 all nonessential, non-pseudo-,
non-ncRNA
total 12 943 12 338 607
aFour oligo subpools were made, intended for knocking out genes by
introduction of a nonsense and frameshift mutation within the first
5% of the CDS (“CDS Knock Outs”), upregulation by insertion of T7
promoters upstream of genes (“T7 promoters”) and insertion of a
consensus RBS sequence (“RBS up”), and down-regulation by inser-
tion of an anti-consensus RBS sequence (“RBS down”). TFs =
Transcription Factors. bOnly genes with sufficient spacing to the next
gene upstream were targeted, to ensure that the insertion of T7 pro-
moters did not disturb upstream genes.
Figure 1.MO-MAGE method for targeted whole genome mutagenesis.
130 base oligonucleotides were designed and synthesized on a DNA
microarray, which can be ordered from several commercial vendors. The
oligos can be designed with different barcodes, which allow selective
PCR amplification of a desired subpool. One of the primers are 5′
phosphorylated, which allow the degradation of only one of the strands
by λ-exonuclease, resulting in single stranded oligos. The barcodes are
removed by enzymatic treatment with endonuclease VIII (cutting the
barcode by removing a uracil from the modified primer), DpnII and a
guide primer (to make a double stranded cut site for DpnII). The final
90 bp single stranded oligos are directly applicable for MAGE.
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We performed a side-by-side comparison of the microarray-
derived oligos with those obtained through standard column-
synthesis from a commercial vendor (Integrated DNA
Technologies, Iowa, U.S.A.). A test group of 5 oligos generated
from the microarray pool and the commercial vendor was used
for MAGE and the efficiency of oligo incorporation was deter-
mined (see Figure 2c). We find that 3 out of the 5 tested oligos
showed slightly lower incorporation efficiencies in the micro-
array library compared to the column library. We attribute the
decreased efficiency to differences in individual oligo concen-
trations that may result during amplification from the microarray
library. Nonetheless, these results offered a convincing proof-
of-concept that microarray-derived oligos are compatible with
MAGE mutagenesis. Since the introduction of synthetic
regulation to native genomic loci has been an outstanding
challenge in synthetic biology, we sought to further explore our
sublibrary that generated T7 promoter insertions in the
untranslated regions (UTR) upstream of each of 2585 operons
in the E. coli genome. This multiplexed promoter insertion
perturbation enables the generation of a mutant library that
contains new transcriptional regulation in the presence of an
inducible T7 polymerase system.9,19 Thus, in this current work,
we focused on characterizing our methods in greater detail using
this T7 insertion library.
The T7 promoter insertion library was designed using
MODEST15 to target the UTR region 40 bp upstream of all
nonessential and nontranscription-factor operons in E. coli.
Downstream polycistronic open reading frames without
adequate intergenic space were not targeted. In all, 2585 unique
insertion target sites were identified.We designed 90 bp oligos by
flanking a 20 bpT7 promoter (TAATACGACTCACTATAGGG)
sequence with 35 bp of homologous sequence at each end to
the target genomic integration site. In general, introduction of a
20 bp insertion is expected to have lower incorporation efficiency
than smaller point mutations or deletions.7 Nonetheless, these
larger insertions represent a unique opportunity to introduce
synthetic regulation and to challenge the limits of our MAGE
capabilities using large oligo library pools derived from micro-
arrays. Furthermore, effective selection of desirable mutants from
a smaller genomic library with T7 promoter insertions have pre-
viously been performed successfully.9
Following the generation of the 2585-oligo library, we applied
this T7 promoter pool to mutagenize the E. coli genome by
MAGE for 12 cycles. The entire oligo processing pipeline and
MAGE mutagenesis was performed twice in parallel to generate
two separate cell libraries to test the reproducibility of our proto-
col. To assess the success of T7 insertion in these combinatorial
libraries, we performed deep sequencing of the final cell popula-
tions. We first extracted genomic DNA of the cell populations
and hybridized the genomic DNA with a biotinylated oligo
containing the T7 promoter sequence. Genomic regions that
contained the T7 promoter insertions can thus be enriched from
total genomic DNA when it is applied to streptavidin beads that
bind to the biotinylated oligo-genomic hybrid. We then
sequenced the enriched genomic library by deep-sequenced to
identify T7 insertion sites.
Next-generation sequencing analysis of the data showed that
the two separate libraries contained 87 reads and 208 reads with
Figure 2. (a) PCR amplicons of the T7 promoter oligo pool can be seen as the strong bands around 130 bp (4% Agarose E-Gel EX with Low Range
Quantitative DNA Ladder). (b) Serial dilutions of the processed single stranded T7 promoter oligo library (left 4 lanes) compared to a reference oligo of
90 bp (right 4 lanes), which indicates correct processing of the oligos from 130 bp to 90 bp oligos ready for MAGE (TBE-Urea gel 4% from Invitrogen).
(c) Comparison of MAGE efficiency using column-synthesized oligos and microarray-processed oligos by MO-MAGE. Gel shows size distribution of
the two processed oligo pools (TBE-Urea gel 4% from Invitrogen).
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the T7 promoter sequence, with the reads mapping to 56 and
98 targeted operons respectively in the two libraries. Only 4 of
the total 154 targets were redundant, resulting in identification
of 150 unique targets out of 2585 possible. The sequencing
coverage (the number of times the genome has been sequenced)
of the libraries was 2064× and 1364× respectively. We used a
Monte Carlo model to simulate the insertion frequency of the
total library, and found that the total cell library is expected to
contain between 2250 and 3500modified genes (95% confidence
interval, see Supporting Information Figure 1). These results
show that all or most of the targeted sites are predicted to have
T7 promoter insertions within the cell library.
We proceeded to further validate our mutagenesis results and
to estimate the insertion efficiency. We randomly selected 12
targets, including 8 that had not been detected by population
sequencing. We amplified ∼200 bp PCR fragments spanning the
T7 insertion sites of each of the 12 genes from the cell library
and sequenced the PCRproducts byNextGeneration Sequencing.
For all 12 loci, we found reads containing the T7 promoter
insertion sequence. This provides further support that the cell
library contains a majority of the 2585 T7 promoter insertions
(see Table 2 and Figure 3).
The insertion frequencies for the 12 loci were estimated by
comparing the number of reads with T7 promoter insertions
to the number of reads without the insertion. The average
frequency was 0.017%, and thus, the average number of
insertions per cell can be estimated as μ = k × p = 0.434 where
p = 0.00017 and k = 2585 targets. This means that 43% of the cell
library is expected to have at least one insertion on average. The
top 1% of the population is expected to have at least four
(4.3) insertions based on the calculations m = μ + 2.326(k ×
p(1 − p))1/2 = 4.3 (for details about the MAGE efficiency
calculations see the Supporting Information as well as Wang and
Church, 20117). The MAGE efficiency for insertions has
previously been predicted based on fitting of empirically
determined efficiencies.7,8 Using such approach, the insertion
efficiency (IE) is IE = 0.15 × e−0.075 × (b−1) = 0.0361, where b is
the size of the insertion in number of bases (b = 20). Based on
this insertion efficiency, the predicted average frequency of each
insertion can be calculated by pN−predicted = 1 − (1 − IE/k)N =
1 − (1 − 0.0361/2585)12 = 0.000167, where N is the number
of MAGE cycles. The predicted average insertion frequency of
0.0167% matches very well with the measured frequency of
0.017%, providing confidence to our predicted population
mutagenesis profile and its applications to analyze MAGE
mutagenesis of complex oligo pools. These results further
highlight that that cell libraries with combinations of multiple
insertions per genome can be generated using this massively
multiplexed approach.
Here, we have presented a proof-of-concept demonstration
for the generation and application of oligo pools that specifically
target thousands of unique chromosomal loci across a cell
population to introduce promoters amenable for synthetic
regulation. The Microarray Oligonucleotide MAGE enables
rapid mutagenesis of bacterial genomes using oligos derived
directly from microarrays without intermediate cloning or
cassette selection steps, which can significantly expand the
combinatorial genomic diversity of the resulting cell population.
A resulting cell library will be useful for various screens for
metabolic engineering purposes such as increased production of
biochemicals or tolerance toward biomass inhibitors. The MO-
MAGE process described here allow researchers to limit the
combinatorial space to only specific mutations that are expected
to have a much higher chance of leading to a desired phenotype
than random mutations. Thus, the effect of rationally designed
targets can be assessed very effectively because the mutagenesis
quality (i.e., the proportion of interesting mutants to other cells)
is much higher. Whereas current approaches are limited to only
creating few genomic changes at a time, our method could be
used to target all predicted beneficial mutations predicted from
metabolic models, and screen for optimal phenotypes.
As the complexity of engineering tasks of synthetic biology and
metabolic engineering increases, the need to reduce cost of
genome engineering becomes more important. MO-MAGE
allows the synthesis of oligos at a fraction of the cost (>1000×)
compared to traditional column based oligo synthesis to make
large-scale genome engineering accessible to most laboratories.
At a price of 36 USD per column-based oligo, MO-MAGE (2800
USD) is currently cost competitive when using more than 78
oligos. This method could provide a paradigm shift by making
large-scale genome engineering of many thousands of targets
available as a standard tool for strain optimization and other
projects where large-scale targeted mutagenesis searches are
needed. New advances in DNA and gene synthesis will further
foster growth in genome engineering of microbial and eukaryotic
systems,20 and in theory, oligo pools containing millions of oligos
can be applied for MO-MAGE. However, since increasing oligo
Table 2. Twelve Genes Randomly Selected for Deep
Amplicon Sequencing and Analysisa
reads with T7 insertion reads total insertion frequency
acrD 549 452814 0.1212%
edd 59 157788 0.0374%
osmC 13 85100 0.0153%
fryB 26 299019 0.0087%
SodB 25 450003 0.0056%
pssA 6 151518 0.0040%
secE 15 561640 0.0027%
thrL 4 197901 0.0020%
GlnD 4 263023 0.0015%
acrA 7 481259 0.0015%
mdaB 2 237727 0.0008%
hemC 1 129353 0.0008%
aThe number of reads with a T7 promoter insertion was compared to
reads without an insertion to calculate the insertion frequency.
Figure 3. MO-MAGE of 2585 genomic targets corresponding to
untranslated regions (UTR) upstream of genes for insertion of 20-bp T7
synthetic promoter. Designed targets are shown in blue. Mutated targets
verified by whole-genome sequencing are shown in red (see Supporting
Information Table 3 for complete list). Mutated targets verified by
amplicon sequencing are shown in black.
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diversity leads to lower replacement efficiency per genomic
target, there is a practical limitation in the number of oligos that
can be meaningfully applied depending on the required
replacement efficiency per site for a given experiment.
For some projects, a higher integration frequency might be
of interest, to allowmore combinations of insertions and a higher
quality library. The amount of MAGE cycles performed can
be increased to higher levels, and automated solutions could
increase the feasible number of MAGE cycles to several
hundreds. For creation of complex libraries where many
combinations per cell are desired, single base pair substitutions
and small insertions and deletions can be applied to increase the
replacement efficiency. For instance if 1000 oligos designed for
making single base pair substitutions are used for 100 cycles of
MAGE, a cell library with 25 average replacements per cell is
predicted. This allows creation of unprecedented targeted
combinatorial libraries of specific chromosomal modifications.
Ultimately, we envision MO-MAGE method will be used to
make thousands of specific chromosomal changes predicted to
result in a desired phenotype and combined with selection or
screening of the cell library for interesting mutants.
■ METHODS
Strains and Culture Conditions.We used a strain based on
the EcNR28 strain for all experiments, which is based on E. coli
K12 MG1655. The genotype is λ-Red+bla+bioA−/bioB−
mutS−zeo+ Lac_T7pol+Spec+ LacIQ+. All strains for MAGE
were grown in low salt LB-min medium (10 g tryptone, 5 g yeast
extract, 5 g NaCl in 1 L dH2O) for optimal electroporation
efficiency with addition of specified antibiotics. All cells for liquid
cultures were grown in standard LB-min medium (10 g tryptone,
5 g yeast extract, 10 g NaCl in 1 L dH2O) with addition of
specified antibiotics.
Standard Oligonucleotides. All standard oligonucleotides
were purchased from Integrated DNA Technologies with
standard purification.
Oligo Library Synthesis. OLS pools were synthesized by
Agilent Technologies and are available upon signing a
Collaborative Technology Development agreement with
Agilent. Costs of OLS pools are a function of the number of
unique oligos synthesized and of the length of the oligos The
OLS pool were synthesized, cleaved, and delivered as lyophilized
∼1−10 picomole pools.
Oligo Library Processing. Please refer to the Supporting
Information.
Oligos for T7 Cell Library Generation.A list of all the 2585
oligos synthesized on the microarray chip designed to insert a
T7 promoter upstream of E. coli genes can be found in the
Supporting Information.
MAGE. MAGE was performed according to the protocol
provided in ref 7. Briefly, the cells were grown to midlog phase,
whereafter the β-protein of the λ-red system was induced by
growing at 42 °C for 15 min whereafter the cells were chilled to
4 °C. The culture were washed to remove salts and resuspended
in cold water (<4 °C). The cells were mixed with the 2 μMoligos
in 50 μL and electroporated in a Bio-Rad MicroPulser, BTX
ECM-830 with 1 mm gap cuvette, whereafter the cells were
incubated for 2−3 h at 30 °C. The process were repeated
12 times (12 MAGE cycles) to allow a higher frequency of
insertion. After 5 and 10 MAGE cycles, the cells were grown
overnight in 50mL LB low salt medium and stored at−80 °C in a
15% v/v glycerol solution.
Enrichment for T7 Promoter Containing Sequences.
The enrichment protocol was based on Gnirke et al.21 and
NimbleGen SeqCap EZ Exome Library SR v2.2 protocol.22 A
biotinylated oligo targeting the T7 promoter was incubated 66 h
with the prepared sequencing library fragments. The T7 pro-
moter containing fragments that hybridized to the biotinylated
oligo was enriched by multiple rounds of binding and washing
with Invitrogen Streptavidin M-270 Dynabeads and Invitrogen
binding and wash buffer.
Illumina DNA Sequencing and Analysis. Samples for
sequencing of the 12 individual strains were processed with
Illumina TruSeq v2 sample prep kit and standard Illumina adapters.
Samples for sequencing of the cell libraries were prepared with the
NEBNext DNA Sample Prep Master Mix Set 1 kit for Illumina
sequencing and manually ordered adaptors kindly provided by
Luhan Yang (Harvard Medical School, George Church Lab).
adaptor 1 PE-A1-F TACACTCTTTCCCTCACGACGCTCTTCGATCTac*T
PE-A1-R /5Phos/gtAGATCGGAGAGCGGTTCAGCGGAATGCCGAG
adaptor 2 PE-A2-F TACACTCTTTCCCTCACGACGCTCTTCGATCTtg*T
PE-A2-R /5Phos/caAGATCGGAGAGCGGTTCAGCGGAATGCCGAG
The libraries were sequenced in two separate lanes, whereas
the 12 isolated strains were sequenced in one lane with multi-
plexing barcodes. The 12 prepared individual strains were sent to
the Harvard Biopolymers facility (genome.med.harvard.edu) for
Illumina sequencing and downloaded to the cbs.dtu.dk server
and processed here. Sequences containing the T7 promoter
sequence were extracted with the “grep” command. BLASTn was
performed in CLC Bio main Workbench 6.0 with standard
settings: “word size” 11, “match” 1, “mismatch” −3, “gap cost
existence” 5, “gap cost extension” 2. Bowtie23 was applied to
perform the alignment of the reads to the reference genomes (see
parameters in the script in Supporting Information). Samtools24
was applied to make a consensus reference genome and indexed
BAM-file (for visual inspection of read alignment) from the
bowtie output (see parameters in the script in Supporting
Information)
PCR and freq-seq of 12 Loci. PCR primers were designed
for amplification of 12 genomic regions of around 200 bp with
the T7 promoter insertion site in the middle. The amplicons
were sequenced on an Illumina MiSeq, and a script created to
extract all WT and mutant sequences and report the numbers.
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